Dr. Nayak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500Fax+1 216-368-1166
Summary
- Dr. Lalitha Nayak is an oncologist in Cleveland, OH and is affiliated with University Hospitals Cleveland Medical Center. She received her medical degree from Goa Medical College and has been in practice 23 years. She specializes in hematologic oncology and is experienced in thrombotic disorders, bleeding disorders, and general / benign hematology.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2001 - 2003
Goa Medical CollegeClass of 1994
Certifications & Licensure
OH State Medical License 2008 - 2026
PA State Medical License 2001 - 2010
KY State Medical License 2007 - 2008- American Board of Internal Medicine Hematology
Clinical Trials
- Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) Start of enrollment: 2014 Oct 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 163 citationsEndothelial Kruppel-like factor 4 protects against atherothrombosis in miceGuangjin Zhou, Anne Hamik, Lalitha Nayak, Hongmei Tian, Hong Shi
The Journal of Clinical Investigation. 2012-12-03 - 409 citationsThe hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, Lalitha Nayak
Thrombosis Research. 2020-06-20 - 71 citationsCancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotidesEnid W. Choi, Lalitha Nayak, Paula J. Bates
Nucleic Acids Research. 2010-03-01
Abstracts/Posters
- Assessment of Bleeding Phenotype in Hemophilia _ By a Novel Point-of-Care Global AssayLalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic PurpuraLalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with NeutrophiliaLalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Friday Scientific Workshop on the Interplay Between Coagulation and Malignancy61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Laboratory & Translational Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Hepatocyte-Derived Tissue Plasminogen Activator Regulates Systemic Fibrinolysis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
The Research Could Lead to Safer Ways to Treat Patients with Blood ClotsOctober 2nd, 2022
Cancer Drug Boosts Levels of Vascular-Protective Gene, KLF2June 12th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
